Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
2.050
-0.010 (-0.49%)
At close: May 18, 2026, 4:00 PM EDT
2.050
0.00 (0.00%)
After-hours: May 18, 2026, 4:10 PM EDT
Annovis Bio Market Cap
Annovis Bio has a market cap or net worth of $71.03 million as of May 18, 2026. Its market cap has increased by 132.16% in one year.
Market Cap
71.03M
Enterprise Value
56.46M
1-Year Change
132.16%
Ranking
Category
Stock Price
$2.05
Market Cap Chart
Since January 29, 2020, Annovis Bio's market cap has increased from $62.51M to $71.03M, an increase of 13.62%. That is a compound annual growth rate of 2.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 71.37M | -22.17% |
| Dec 31, 2025 | 91.70M | 32.13% |
| Dec 31, 2024 | 69.40M | -63.84% |
| Dec 29, 2023 | 191.90M | 75.03% |
| Dec 30, 2022 | 109.64M | -23.01% |
| Dec 31, 2021 | 142.41M | 174.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rallybio | 75.85M |
| Acrivon Therapeutics | 75.33M |
| XBiotech | 75.00M |
| Gain Therapeutics | 74.64M |
| Cue Biopharma | 74.38M |
| Seres Therapeutics | 73.11M |
| OS Therapies | 71.25M |
| Pliant Therapeutics | 71.21M |